Skip to main content
Clinical Trials/NCT05245110
NCT05245110
Unknown
Not Applicable

Tri-Service General Hospital, National Defense Medical Center

Tri-Service General Hospital1 site in 1 country200 target enrollmentApril 1, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Diseases
Sponsor
Tri-Service General Hospital
Enrollment
200
Locations
1
Primary Endpoint
Changes from baseline VO2 peak (ml/kg/min) at 12 weeks
Last Updated
4 years ago

Overview

Brief Summary

This trial aimed to assess whether assumed increase in physical activity after tele-exercise training can improve cardiorespiratory fitness of patients with cardiometabolic multimorbidity.

Detailed Description

A parallel-group randomized controlled trial was conducted. Eligible patients with cardiometabolic multimorbidity were randomized 1:1 to either experimental group (EG, received a tele-exercise training program) or control group (CG, usual care only). The intervention encompassed tele-exercise training program (30 min/session, 3 sessions/week) and weekly remote monitoring for maintenance of exercise. Physical activity and cardiorespiratory fitness were assessed at baseline and 12 weeks. Generalized estimating equations were used to examine the intervention effects via the interaction of time and group.

Registry
clinicaltrials.gov
Start Date
April 1, 2018
End Date
December 31, 2022
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

CHIA-HUEI LIN, PhD

Associate Professor and Deputy Director of Nursing Department

Tri-Service General Hospital

Eligibility Criteria

Inclusion Criteria

  • Confirmed diagnoses of cardiometabolic multimorbidity, defined as the presence of two or more cardiometabolic conditions (i.e., hypertension, type 2 diabetes, hyperlipidaemia, heart disease, metabolic syndrome, or gout)
  • Aged 18-80 years
  • Able to speak and understand Mandarin
  • Able to walk without assistance
  • Had mobile phones and could easily access the Internet

Exclusion Criteria

  • Not match the diagnosis of cardiometabolic multimorbidity; and a history of arrhythmia, cancer, end-stage renal disease with dialysis, being diagnosed with mental illness, recent stroke within 6 months
  • Not able to speak and understand Mandarin
  • Not able to walk independently or inability to participate due to comorbid neurological, musculoskeletal conditions that produce moderate-to-severe physical disability
  • Did not have mobile phones or could not access the internet at home and whenever necessary

Outcomes

Primary Outcomes

Changes from baseline VO2 peak (ml/kg/min) at 12 weeks

Time Frame: 12 weeks

VO2 peak (ml/kg/min), detected during graded exercise testing, performed using a motorized ergometer (Corival, Lode, Netherlands) with a standardized ramp protocol by increasing the resistance (10 watt per minute) at a consistent speed of 60 revolutions per minute.

Changes from baseline resting heart rate (bpm) at 12 weeks

Time Frame: 12 weeks

Resting heart rate (bpm) obtained using electronic BP monitor devices (Terumo, ESP2000)

Changes from baseline One-min heart rate recovery (beat) at 12 weeks

Time Frame: 12 weeks

One-min heart rate recovery (beat), detected during graded exercise testing, performed using a motorized ergometer (Corival, Lode, Netherlands) with a standardized ramp protocol by increasing the resistance (10 watt per minute) at a consistent speed of 60 revolutions per minute.

Changes form baseline forced expiratory volume in one second (L/min) at 12 weeks

Time Frame: 12 weeks

forced expiratory volume in one second (L/min), detected during graded exercise testing, performed using a motorized ergometer (Corival, Lode, Netherlands) with a standardized ramp protocol by increasing the resistance (10 watt per minute) at a consistent speed of 60 revolutions per minute.

Changes from baseline BNP at 12 weeks

Time Frame: 12 weeks

BNP through blood analysis

Changes from baseline workload (Watts)at 12 weeks

Time Frame: 12 weeks

Workload (Watts), detected during graded exercise testing, performed using a motorized ergometer (Corival, Lode, Netherlands) with a standardized ramp protocol by increasing the resistance (10 watt per minute) at a consistent speed of 60 revolutions per minute.

Changes from baseline O2 pulse (ml/beat) at 12 weeks

Time Frame: 12 weeks

O2 pulse (ml/beat), detected during graded exercise testing, performed using a motorized ergometer (Corival, Lode, Netherlands) with a standardized ramp protocol by increasing the resistance (10 watt per minute) at a consistent speed of 60 revolutions per minute.

Changes from baseline Two-min heart rate recovery (beat) at 12 weeks

Time Frame: 12 weeks

Two-min heart rate recovery (beat), detected during graded exercise testing, performed using a motorized ergometer (Corival, Lode, Netherlands) with a standardized ramp protocol by increasing the resistance (10 watt per minute) at a consistent speed of 60 revolutions per minute.

Changes from baseline physical activity amount at 12 weeks

Time Frame: 12 weeks

weekly amount of physical activity using the well-validated and reliable Taiwan version of 7-item International Physical Activity Questionnaire to measure. The scores of International Physical Activity Questionnaire expressed as "MET-minutes/week". Higher score indicates higher physical activity amounts

Changes from baseline anaerobic threshold at 12 weeks

Time Frame: 12 weeks

anaerobic threshold, detected during graded exercise testing, performed using a motorized ergometer (Corival, Lode, Netherlands) with a standardized ramp protocol by increasing the resistance (10 watt per minute) at a consistent speed of 60 revolutions per minute.

Changes from baseline Resting Systolic Blood Pressure (mmHg) at 12 weeks

Time Frame: 12 weeks

Resting Systolic Blood Pressure (mmHg) obtained using electronic BP monitor devices (Terumo, ESP2000)

Changes from baseline Resting Diastolic Blood Pressure (mmHg) at 12 weeks

Time Frame: 12 weeks

Resting Diastolic Blood Pressure (mmHg), obtained using electronic BP monitor devices (Terumo, ESP2000)

Changes from baseline forced vital capacity (L/min) at 12 weeks

Time Frame: 12 weeks

forced vital capacity (L/min), detected during graded exercise testing, performed using a motorized ergometer (Corival, Lode, Netherlands) with a standardized ramp protocol by increasing the resistance (10 watt per minute) at a consistent speed of 60 revolutions per minute.

Changes from baseline FEV1/FVC (%) at 12 weeks

Time Frame: 12 weeks

FEV1/FVC (%) detected during graded exercise testing, , performed using a motorized ergometer (Corival, Lode, Netherlands) with a standardized ramp protocol by increasing the resistance (10 watt per minute) at a consistent speed of 60 revolutions per minute.

Changes from baseline Ejection fraction (%) at 12 weeks

Time Frame: Baseline and 12 weeks

Ejection fraction (%) data were collected through chart review

Changes from baseline Health-related quality of life at 12 weeks

Time Frame: 12 weeks

Health-related quality of life useing the reliable and valid Taiwan version of Medical Outcomes Study Short-Form 36 to measure. Scores ranged from 0 to 100, with higher scores indicating better health-related quality of life.

Study Sites (1)

Loading locations...

Similar Trials